Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

Alternative to high risk surgery? New TAVI device approved in Europe

A new transcatheter aortic valve implantation (TAVI) by Boston Scientific has received market approval in Europe.

Thumbnail

Earlier menopause could increase risk for poor cardiovascular outcomes

Women who experience menopause earlier are at greater risk for cardiovascular issues such as heart disease and stroke and even have greater all-cause mortality rates than women who experience menopause nearer the average age of 51, according to a new study published in the Journal of the American Medical Association Cardiology. 

New sound therapy can reduce blood pressure in hypertensive patients

A new noninvasive neurotechnology has been shown to lower blood pressure, improve heart rate variability and reduced migraine symptoms.

Thumbnail

Chronic kidney disease, hypertension are common after children undergo cardiac surgery

Children typically have chronic kidney disease and hypertension five years after undergoing cardiac surgery, according to a prospective, multicenter cohort study. The outcomes were similar whether or not children had perioperative acute kidney injury.

Probiotics do the heart good

In case Jamie Lee Curtis’ Activia advertisements praising the health benefits of probiotics wasn’t enough, new research suggests that the live bacteria and yeast may one day aid in the treatment of pulmonary hypertension.

FDA clears Shockwave Medical’s lithoplasty system for patients with peripheral artery disease

The FDA cleared Shockwave Medical’s lithoplasty system Sept. 16 to treat calcified plaque in patients with peripheral artery disease.

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty System for the treatment of calcified plaque in patients with peripheral artery disease (PAD).

Thumbnail

From the Ground Up: Building a Better Interventional Program

Offered in cooperation with Abiomed

San Juan Regional Medical Center's ongoing training and protocols has served the heart team well and their advice is solid for care providers seeking to offer quality care while maintaining a healthy bottom line.

Displaying 6297 - 6304 of 10755

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.